Clinical Trial Update: "The Effect of Inhaled Nitroglycerin for COPD Patients [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial is evaluating inhaled nitroglycerin for chronic obstructive pulmonary disease and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Inhaled nitroglycerin (nitroglycerin)

Snippet

Sponsor: Beni-Suef University | Conditions: COPD, COPD III/IV | Phase 2, Phase 3 | Status: RECRUITING